Jean‐Baptiste Hiriart

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen et al. · The Lancet Oncology · 2019 · 1.6K citations

Oncology, Hepatology, α-Fetoprotein Concentrations +10

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

Christophe Cassinotto, Jérôme Boursier, Victor de Lédinghen et al. · Hepatology · 2015 · 503 citations · Full text

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease

Jérôme Boursier, Julien Vergniol, A. Guillet et al. · Journal of Hepatology · 2016 · 386 citations

Metabolic Syndrome, Fibrosis, Metabolic Associated Steatohepatitis +14

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations

Victor de Lédinghen, Julien Vergniol, Maylis Capdepont et al. · Journal of Hepatology · 2014 · 365 citations

Hepatology, Medicine, Diagnosis +5

Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan®

Christophe Cassinotto, Bruno Lapuyade, Amaury Mouries et al. · Journal of Hepatology · 2014 · 323 citations

Liver Fibrosis, Impulse Elastography, Hepatology +8